Gary A. Gintant - Concepedia

Author

Gary A. Gintant

Also Known As

G A Gintant, G GINTANT, G. A. Gintant, G. Gintant, G.A. Gintant, GARY A. GINTANT, Gary A Gintant, Gary A. Gintant, Gary Gintant

148

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund AbbVie (United States)Health and Environmental Sciences Institute Abbott (United Kingdom)Abbott (United States)

About

Gary A. Gintant is an author at Abbott Fund specializing in medicine, cardiology, and electrophysiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	37	3.4K
2	Public Health	7	7	1.4K
3	Engineering	4	4	638
4	Natural Sciences	4	4	138
5	Business	1	1	20

Gary A. Gintant

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium Philip T. Sager, Gary A. Gintant, J. Rick Turner, American Heart Journal Heart FailureCardiac AnaesthesiaWhite PaperSafety SciencePharmacotherapy	2013	536
Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. D W Liu, Gary A. Gintant, Charles Antzelevitch Circulation Research Cardiac MuscleEngineeringBiomedical EngineeringCellular PhysiologyFree Wall	1993	462
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress Thomas Colatsky, Bernard Fermini, Gary A. Gintant, Journal of Pharmacological and Toxicological Methods Cardiac MuscleHeart FailureHerg BlockPharmacotherapyIch S7b	2016	443
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment Ksenia Blinova, Qianyu Dang, Daniel Millard, Cell Reports	2018	358
The Utility of hERG and Repolarization Assays in Evaluating Delayed Cardiac Repolarization: Influence of Multi-Channel Block Ruth L. Martin, Jeff S. McDermott, Heinz J. Salmen, Journal of Cardiovascular Pharmacology Cardiac MuscleHeart FailurePharmacotherapyBiomedical EngineeringExperimental Pharmacology	2004	179
Tissue and Species Distribution of mRNA for the i<sub>kr</sub>-like K<sup>+</sup>Channel, ERG Randy S. Wymore, Gary A. Gintant, Rigel T. Wymore, Circulation Research	1997	170
The Canine Purkinje Fiber: An In Vitro Model System for Acquired Long QT Syndrome and Drug-Induced Arrhythmogenesis Gary A. Gintant, James T. Limberis, Jeff S. McDermott, Journal of Cardiovascular Pharmacology Cardiac MuscleHeart FailurePathologyPharmacotherapyVitro Model System	2001	159
Two Components of Delayed Rectifier Current in Canine Atrium and Ventricle Gary A. Gintant Circulation Research	1996	138
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study Daniel Millard, Qianyu Dang, Hong Shi, Toxicological Sciences Tissue EngineeringCardiac MuscleHeart FailureEngineeringCardiac Safety Studies	2018	126
Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics Hugo M. Vargas, Alan Bass, Alexander Breidenbach, Journal of Pharmacological and Toxicological Methods Cardiovascular Translational ResearchCardiovascular DiseaseScientific ReviewCardiologyCardiovascular Toxicity	2008	124

Page 1